Washington, D.C. 20549

(Exact name of registrant as specified in its charter)

FLORIDA		000-22052		65-0202059
(State or other jurisdiction of incorporation)		(Commission File No.)		(IRS Employer Identification No.)

(Registrant’s telephone number, including area code)

(954) 473-1001
(Former telephone number of registrant)

---

---

 

Explanatory Note

     This Form 8-K/A amends Item 7 of the Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on March 5, 2004, by ProxyMed, Inc., a Florida corporation (the “Company”), in connection with the merger of Planet Acquisition Corp., a Delaware Corporation and a wholly-owned subsidiary of the Company (the “Acquisition Subsidiary”) with and into PlanVista Corporation (“PlanVista”) upon the terms and conditions set forth in the Agreement and Plan of Merger, dated December 5, 2003, by and among the Company, the Acquisition Subsidiary and PlanVista.

Item 7. Financial Statements and Exhibits.

(a) Financial statements of business acquired.

(1) The historical consolidated financial statements of PlanVista including PlanVista’s consolidated balance sheet at December 31, 2002 and 2001, and the consolidated statements of operations, cash flows and stockholders’ equity for each of the years ended December 31, 2002, 2001 and 2000 were previously filed by the Company with the SEC in the Registration Statement on Form S-4 (File No. 333-111024) (the “Registration Statement”).

(2) The unaudited consolidated financial statements of PlanVista including PlanVista’s unaudited consolidated balance sheet at September 30, 2003 and the unaudited consolidated statements of operations and cash flows for the three months ended September 30, 2003, and 2002 were previously filed by the Company with the SEC in the Registration Statement.

(b) Pro forma financial information.

The unaudited pro forma condensed combined consolidated financial statements of the Company as of and for the nine months ended September 30, 2003 and for the year ended December 31, 2002 giving effect to the merger as a purchase of PlanVista by the Company in accordance with Article 11 of Regulation S-X were previously filed by the Company with the SEC in the Registration Statement.

2

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ProxyMed, Inc.
Date: March 15, 2004	/s/ Gregory J. Eisenhauer
	Gregory J. Eisenhauer
	Executive Vice President and Chief Financial Officer

3